301230.SZ
PharmaResources (Shanghai) Co., Ltd
SZSE · M 科研服务 · CN
CNY 33.84
−5.26%Year over year
Reported trailing growth
- Revenue
- +18.5%
- EBITDA
- —
- EBIT
- +238.0%
- EPS
- +81.6%
- Free cash flow
- +512.8%
- Operating cash flow
- +139.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.9%
- EBITDA
- +0.6%
- EBIT
- -26.8%
- Net income
- -20.1%
- EPS
- -31.9%
- Free cash flow
- +423.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026